Performance of parallel screening of Brazilian blood donors with two human immunodeficiency virus immunoassays: Implications for sequential immunoassay testing algorithms in other countries

Transfusion

Volumn 51, Issue 1, 2011, Pages 175-183

  Sabino, Ester C ^a,b,c,d   Salles, Nanci A ^a,b,c,d   De Almeida Neto, Cesar ^a,b,c,d   Barreto, Angela M ^a,b,c,d   Basques, Fernando ^a,b,c,d   Barros, Emanuelle A ^a,b,c,d   Mendrone Jr, Alfredo ^a,b,c,d   Busch, Michael P ^a,b,c,d  

^a Fundao Pro Sangue   (Brazil)

^b Fundaçã Hemominas   (Brazil)

^c Fundaçã Hemope Recife   (Brazil)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BRAZIL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

EID: 78651361904     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02773.x     Document Type: Article

References (17)

1. o 488 de 17 de junho de 1998. Brasilia: Agência Nacional de Vigilância Sanitária: Diário Oficial da União; 1998. p. 3-4.
2. Camargo ME, Segura EL, Kagan IG, Souza JM, Carvalheiro Jda R, Yanovsky JF, Guimarães MC,. Three years of collaboration on the standardization of Chagas' disease serodiagnosis in the Americas: an appraisal. Bull Pan Am Health Organ 1986; 20: 233-44.
3. Carneiro-Proietti AB, Sabino EC, Sampaio D, Proietti FA, GonÃalez TT, Oliveira CD, Ferreira JE, Liu J, Custer B, Schreiber GB, Murphy EL, Busch MP,. Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008. Transfusion 2010; 50: 918-25.
4. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L, Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 2003; 43: 226-34.
5. Owen SM, Yang C, Spira T, Ou CY, Pau CP, Parekh BS, Candal D, Kuehl D, Kennedy MS, Rudolph D, Luo W, Delatorre N, Masciotra S, Kalish ML, Cowart F, Barnett T, Lal R, McDougal JS,. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008; 46: 1588-95.
6. van der Groen G, Van Kerckhoven I, Vercauteren G, Piot P,. Simplified and less expensive confirmatory HIV testing. Bull World Health Organ 1991; 69: 747-52.
7. Joint United Nations Programme on HIV/AIDS (UNAIDS)-WHO. Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997; 72: 81-7.
8. Bennett B, Branson B, Delaney K, Owen M, Pentella M, Werner B,. HIV testing algorithms a status report, 2009 [monograph on the internet]. Silver Spring (MD): The Association of Public Health Laboratories and the centers for Disease Control and Prevention; 2009. [cited 2010 Jun 23]. Available from
9. Candotti D, Temple J, Owusu-Ofori S, Allain JP,. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods 2004; 118: 39-47.
10. Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP,. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr 2003; 33: 349-55.
11. Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989; 38: 1-7.
12. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP,. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871-9.
13. Guan M,. Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus. Clin Vaccine Immunol 2007; 14: 649-59.
14. Laperche S,. Antigen-antibody combination assays for blood donor screening: weighing the advantages and costs. Transfusion 2008; 48: 576-9.
15. Pilcher CD, Christopoulos KA, Golden M,. Public health rationale for rapid nucleic acid or p24 antigen tests for HIV. J Infect Dis 2010; 201 Suppl 1: S7-15.
16. Sickinger E, Jonas G, Yem AW, Goller A, Stieler M, Brennan C, Hausmann M, Schochetman G, Devare SG, Hunt JC, Kapprell HP, Bryant JD,. Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening. Transfusion 2008; 48: 584-93.
17. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O'Brien DP,. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One 2009; 4: e4351.